Evidence map›Paper›PMID 34083746›Full record

ArticleCommunications biology2021

The chaperonin CCT8 controls proteostasis essential for T cell maturation, selection, and function.

Bergithe E Oftedal, Stefano Maio, Adam E Handel, Madeleine P J White, Duncan Howie, Simon Davis, Nicolas Prevot, Ioanna A Rota, Mary E Deadman, Benedikt M Kessler and 5 more

Open access · goldAbstract read
In one paragraph

Article in Communications biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Chaperonin in health and disease.Molecular biomedicine · 2026
    Review
  3. Article
  4. Recent advances in nuclear actin research.Nucleus (Austin, Tex.) · 2025
    Review
  5. Article
  6. Review
  7. Article
  8. Proteostasis in T cell aging.Seminars in immunology · 2023
    Review
  9. Article
  10. Article
  11. The TRiCky Business of Protein Folding in Health and Disease.Frontiers in cell and developmental biology · 2022
    Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 5 countries.

Bergithe E Oftedal *Developmental Immunology, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, OX3 9DS, UK.ORCID 0000-0003-4248-7737
Stefano Maio *Developmental Immunology, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, OX3 9DS, UK.ORCID 0000-0001-9518-6466
Adam E HandelDevelopmental Immunology, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, OX3 9DS, UK.ORCID 0000-0001-8385-6346
Madeleine P J WhiteWellcome Centre for Integrative Parasitology, Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, G12 8TA, UK.
Duncan HowieSir William Dunn School of Pathology, University of Oxford, Oxford, OX1 3RE, UK.
Simon DavisTarget Discovery Institute, Nuffield Department of Medicine, University of Oxford, Oxford, OX3 7FZ, UK.ORCID 0000-0001-7840-2411
Nicolas PrevotDevelopmental Immunology, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, OX3 9DS, UK.
Ioanna A RotaDevelopmental Immunology, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, OX3 9DS, UK.
Mary E DeadmanDevelopmental Immunology, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, OX3 9DS, UK.
Benedikt M KesslerTarget Discovery Institute, Nuffield Department of Medicine, University of Oxford, Oxford, OX3 7FZ, UK.ORCID 0000-0002-8160-2446
Roman FischerTarget Discovery Institute, Nuffield Department of Medicine, University of Oxford, Oxford, OX3 7FZ, UK.ORCID 0000-0002-9715-5951
Nikolaus S TredeHuntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
Erdinc SezginMRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, OX3 9DS, UK.ORCID 0000-0002-4915-388X
Rick M MaizelsWellcome Centre for Integrative Parasitology, Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, G12 8TA, UK.
Georg A HolländerDevelopmental Immunology, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, OX3 9DS, UK. georg.hollander@paediatrics.ox.ac.uk.ORCID 0000-0002-8790-0874
University of Oxford · GBWellcome Centre for Molecular Parasitology · GBScience for Life Laboratory · SEUniversity of Basel · CHUniversity of Utah · US

Funding

Wellcome Trust
6 · The paper itself

Abstract

T cells rely for their development and function on the correct folding and turnover of proteins generated in response to a broad range of molecular cues. In the absence of the eukaryotic type II chaperonin complex, CCT, T cell activation induced changes in the proteome are compromised including the formation of nuclear actin filaments and the formation of a normal cell stress response. Consequently, thymocyte maturation and selection, and T cell homeostatic maintenance and receptor-mediated activation are severely impaired. In the absence of CCT-controlled protein folding, Th2 polarization diverges from normal differentiation with paradoxical continued IFN-γ expression. As a result, CCT-deficient T cells fail to generate an efficient immune protection against helminths as they are unable to sustain a coordinated recruitment of the innate and adaptive immune systems. These findings thus demonstrate that normal T cell biology is critically dependent on CCT-controlled proteostasis and that its absence is incompatible with protective immunity.

Indexed as

AnimalsCD4-Positive T-LymphocytesCell DifferentiationCells, CulturedChaperonin Containing TCP-1HumansLymphocyte ActivationMiceMice, Inbred C57BLMice, KnockoutProteomeProteostasisThymocytesT-LymphocytesTranscriptomeTumor Necrosis Factor-alphaChaperonin Containing TCP-1ProteomeTumor Necrosis Factor-alpha

Identifiers

PMID34083746
PMCPMC8175432
OpenAlexW3165457665

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.